These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21487251)

  • 1. Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy.
    Prendergast A; Bwakura-Dangarembizi MF; Cook AD; Bakeera-Kitaka S; Natukunda E; Nahirya Ntege P; Nathoo KJ; Karungi C; Lutaakome J; Kekitiinwa A; Gibb DM
    AIDS; 2011 Apr; 25(7):951-6. PubMed ID: 21487251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe.
    Prendergast AJ; Berejena C; Pimundu G; Shonhai A; Bwakura-Dangarembizi M; Musiime V; Szubert AJ; Cook AD; Spyer MJ; Nahirya-Ntege P; Kekitiinwa A; Gibb DM; Klein N; Walker AS
    AIDS; 2019 Jul; 33(9):1485-1490. PubMed ID: 31008797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART).
    Taye B; Shiferaw S; Enquselassie F
    Ethiop Med J; 2010 Jan; 48(1):1-10. PubMed ID: 20607992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth in the first 5 years after antiretroviral therapy initiation among HIV-infected children in the IeDEA West African Pediatric Cohort.
    Jesson J; Ephoevi-Ga A; Desmonde S; Ake-Assi MH; D'Almeida M; Sy HS; Malateste K; Amorissani-Folquet M; Dicko F; Kouadio K; Renner L; Leroy V;
    Trop Med Int Health; 2019 Jun; 24(6):775-785. PubMed ID: 30945378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
    Munderi P; Walker AS; Kityo C; Babiker AG; Ssali F; Reid A; Darbyshire JH; Grosskurth H; Mugyenyi P; Gibb DM; Gilks CF;
    HIV Med; 2010 May; 11(5):334-44. PubMed ID: 20136661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe malnutrition with and without HIV-1 infection in hospitalised children in Kampala, Uganda: differences in clinical features, haematological findings and CD4+ cell counts.
    Bachou H; Tylleskär T; Downing R; Tumwine JK
    Nutr J; 2006 Oct; 5():27. PubMed ID: 17042940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection in malnourished children in Harare, Zimbabwe.
    Ticklay IM; Nathoo KJ; Siziya S; Brady JP
    East Afr Med J; 1997 Apr; 74(4):217-20. PubMed ID: 9299820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral Therapy in Severely Malnourished, HIV-infected Children in Asia.
    Boettiger DC; Aurpibul L; Hudaya DM; Fong SM; Lumbiganon P; Saphonn V; Truong KH; Hansudewechakul R; Nguyen LV; Do VC; Bunupuradah T; Chokephaibulkit K; Nik Yusoff NK; Kumarasamy N; Wati DK; Razali KA; Kariminia A;
    Pediatr Infect Dis J; 2016 May; 35(5):e144-51. PubMed ID: 26835972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
    PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
    Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
    BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy.
    Bandyopadhyay A; Bhattacharyya S
    Ann Trop Paediatr; 2008 Dec; 28(4):279-85. PubMed ID: 19021944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi.
    Weigel R; Phiri S; Chiputula F; Gumulira J; Brinkhof M; Gsponer T; Tweya H; Egger M; Keiser O
    Trop Med Int Health; 2010 Aug; 15(8):934-44. PubMed ID: 20561308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.
    Jesson J; Koumakpaï S; Diagne NR; Amorissani-Folquet M; Kouéta F; Aka A; Lawson-Evi K; Dicko F; Kouakou K; Pety T; Renner L; Eboua T; Coffie PA; Desmonde S; Leroy V;
    Pediatr Infect Dis J; 2015 Jul; 34(7):e159-68. PubMed ID: 25955835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
    Bwakura-Dangarembizi M; Kendall L; Bakeera-Kitaka S; Nahirya-Ntege P; Keishanyu R; Nathoo K; Spyer MJ; Kekitiinwa A; Lutaakome J; Mhute T; Kasirye P; Munderi P; Musiime V; Gibb DM; Walker AS; Prendergast AJ
    N Engl J Med; 2014 Jan; 370(1):41-53. PubMed ID: 24382064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.
    Bolton-Moore C; Mubiana-Mbewe M; Cantrell RA; Chintu N; Stringer EM; Chi BH; Sinkala M; Kankasa C; Wilson CM; Wilfert CM; Mwango A; Levy J; Abrams EJ; Bulterys M; Stringer JS
    JAMA; 2007 Oct; 298(16):1888-99. PubMed ID: 17954540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization trends, costs, and risk factors in HIV-infected children on antiretroviral therapy.
    Collins IJ; Cairns J; Jourdain G; Fregonese F; Nantarukchaikul M; Lertpienthum N; Wannarit P; Attavinijtrakarn P; Layangool P; Le Coeur S; Lallemant M;
    AIDS; 2012 Sep; 26(15):1943-52. PubMed ID: 22824633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trial.
    Njuguna IN; Cranmer LM; Otieno VO; Mugo C; Okinyi HM; Benki-Nugent S; Richardson B; Stern J; Maleche-Obimbo E; Wamalwa DC; John-Stewart GC
    Lancet HIV; 2018 Jan; 5(1):e12-e22. PubMed ID: 29150377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
    Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
    BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load.
    Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L
    BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.